Syndax Pharmaceuticals, Inc. (SNDX)

Healthcare · Biotechnology · NASDAQ

Syndax Pharmaceuticals, Inc. (SNDX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.62B and a free-cash-flow yield of -20.5%. Over the most recent reported fiscal year, revenue grew 627.8%.

Market cap	$1.62B
Trailing P/E	—
FCF yield	-20.5%
Revenue growth (YoY)	+627.8%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live SNDX data on Nama Insights →